Michael Ulz's Stock Ratings

Morgan Stanley Analyst

Michael Ulz is an analyst at Morgan Stanley. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/17/2024

Overall Average Return

35.8%

Smart Score

Overall Average Return Percentile

90th

Number of Ratings

102

		Buy Now							Get Alert
05/13/2024	ARWR	Buy Now	Arrowhead Pharma	$24.82	8.78%	$36 → $27	Maintains	Equal-Weight	Get Alert
05/10/2024	MIRM	Buy Now	Mirum Pharmaceuticals	$24.81	113.62%	$57 → $53	Maintains	Overweight	Get Alert
04/30/2024	DYN	Buy Now	Dyne Therapeutics	$35.50	12.68%	→ $40	Initiates	→ Overweight	Get Alert
Make more informed trades with Benzinga Pro You're only getting a peek at the whole story!
04/22/2024	SLN	Buy Now	Silence Therapeutics	$23.35	92.72%	$45 → $45	Maintains	Overweight	Get Alert
04/11/2024	ALPN	Buy Now	Alpine Immune Sciences	$64.99	0.02%	$47 → $65	Downgrade	Overweight → Equal-Weight	Get Alert
03/19/2024	ALPN	Buy Now	Alpine Immune Sciences	$64.99	-27.68%	$30 → $47	Maintains	Overweight	Get Alert
03/14/2024	SLN	Buy Now	Silence Therapeutics	$23.35	92.72%	$29 → $45	Maintains	Overweight	Get Alert
03/04/2024	KYTX	Buy Now	Kyverna Therapeutics	$14.40	177.78%	→ $40	Initiates	→ Overweight	Get Alert
02/27/2024	FATE	Buy Now	Fate Therapeutics	$4.10	70.73%	$3 → $7	Maintains	Equal-Weight	Get Alert
02/27/2024	GUTS	Buy Now	Fractyl Health	$6.75	166.67%	→ $18	Initiates	→ Overweight	Get Alert
02/13/2024	ALNY	Buy Now	Alnylam Pharmaceuticals	$148.04	18.89%	$184 → $176	Maintains	Equal-Weight	Get Alert
02/07/2024	ARWR	Buy Now	Arrowhead Pharma	$24.82	45.04%	$34 → $36	Maintains	Equal-Weight	Get Alert
11/30/2023	ARWR	Buy Now	Arrowhead Pharma	$24.82	49.07%	$40 → $37	Maintains	Equal-Weight	Get Alert
11/29/2023	CABA	Buy Now	Cabaletta Bio	$12.88	94.1%	$28 → $25	Maintains	Overweight	Get Alert
11/13/2023	FATE	Buy Now	Fate Therapeutics	$4.10	-26.83%	$5 → $3	Maintains	Equal-Weight	Get Alert
11/13/2023	MIRM	Buy Now	Mirum Pharmaceuticals	$24.81	141.84%	→ $60	Initiates	→ Overweight	Get Alert
11/08/2023	CABA	Buy Now	Cabaletta Bio	$12.88	117.39%	$16 → $28	Maintains	Overweight	Get Alert
11/03/2023	IONS	Buy Now	Ionis Pharmaceuticals	$38.72	23.97%	$45 → $48	Maintains	Equal-Weight	Get Alert
11/03/2023	ALPN	Buy Now	Alpine Immune Sciences	$64.99	-53.84%	$17 → $30	Maintains	Overweight	Get Alert
11/03/2023	ALNY	Buy Now	Alnylam Pharmaceuticals	$148.04	23.61%	$175 → $183	Maintains	Equal-Weight	Get Alert
10/27/2023	BPMC	Buy Now	Blueprint Medicines	$104.26	-39.57%	$59 → $63	Maintains	Equal-Weight	Get Alert
10/11/2023	AKRO	Buy Now	Akero Therapeutics	$20.14	63.85%	$70 → $33	Maintains	Overweight	Get Alert
10/10/2023	ALNY	Buy Now	Alnylam Pharmaceuticals	$148.04	18.21%	$210 → $175	Maintains	Equal-Weight	Get Alert
09/27/2023	IONS	Buy Now	Ionis Pharmaceuticals	$38.72	16.22%	$42 → $45	Maintains	Equal-Weight	Get Alert
08/16/2023	ORIC	Buy Now	ORIC Pharmaceuticals	$9.08	197.36%	$15 → $27	Maintains	Outperform	Get Alert
08/14/2023	YMAB	Buy Now	Y-mAbs Therapeutics	$11.82	-57.7%	$7 → $5	Maintains	Underweight	Get Alert
08/11/2023	THRD	Buy Now	Third Harmonic Bio	$14.40	-51.39%	$5 → $7	Maintains	Equal-Weight	Get Alert
08/10/2023	FATE	Buy Now	Fate Therapeutics	$4.10	21.95%	$8 → $5	Maintains	Equal-Weight	Get Alert
08/09/2023	MRTX	Buy Now	Mirati Therapeutics	—	—	$42 → $37	Maintains	Equal-Weight	Get Alert
08/07/2023	KPTI	Buy Now	Karyopharm Therapeutics	$1.15	247.83%	$5 → $4	Maintains	Equal-Weight	Get Alert